Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[CORONARY ARTERY DISEASE AND HEART FAILURE: A GENOTYPE-BASED THERAPEUTIC APPROACH].

Revue medicale de Liege - 1 Jan 2000

Lancellotti P, Ancion A

Abstract excerpt

Phenotypic approach of the treatment of coronary artery disease and heart failure used in prospective randomized trials has contributed to significantly improve patieni prognosis. However, gene polymorphisms have been shown to be able to alter treatment efficacy with anti-platelets, beta-blockers or ACE-inhibitors in these settings. As suggested by several studies, therapeutic approaches based on genotype should...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme Inhibitors
Share to Adrenergic beta-Antagonists
Share to Coronary Artery Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ACE gene

Share to Genotype

Share to Heart Failure

Share to Platelet Aggregation Inhibitors

Share to Precision Medicine

Source

Identifiers

PMID: 26285453

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[CORONARY ARTERY DISEASE AND HEART FAILURE: A GENOTYPE-BASED THERAPEUTIC APPROACH].PMID 26285453Read ↗

[Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].Semantic proximity Read ↗

Personalized medicine in cardiology: the time for genotype-guided therapy is now.Semantic proximity Read ↗

Efficacy and safety of genotype-guided antiplatelet therapy versus standard treatment in 4,604 patients with CAD after PCI: a meta-analysis of randomized controlled trials.Semantic proximity Read ↗

[Genotype-guided antithrombotic therapy].Semantic proximity Read ↗

Genotype-Guided Antiplatelet Therapy Versus Standard Therapy for Patients with Coronary Artery Disease: An Updated Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Genotype-guided antiplatelet therapy compared with standard therapy for patients with acute coronary syndromes or undergoing percutaneous coronary intervention: A systematic review and meta-analysis.Semantic proximity Read ↗

Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).Semantic proximity Read ↗

[Genetic polymorphism in ischemic heart disease].Semantic proximity Read ↗

Genotype-based clinical trials in cardiovascular disease.Semantic proximity Read ↗

[Cardiovascular pharmacogenomics].Semantic proximity Read ↗

Clopidogrel in acute coronary syndrome: to genotype or not?Semantic proximity Read ↗

Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk - Never Judge a Book by Its Cover.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.